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Purpose: To compare the patterns of uveitis, emphasizing similarities and discrepancies, 
in the Middle East and Europe.
Methods: Six articles reporting uveitis patterns from the Middle East including a 
total of 2,693 cases, and seven articles with a sum of 4,379 cases from Europe were 
analyzed and patterns in each region were defined and compared.
Results: In both regions, uveitis was most commonly seen in the fourth decade of 
life with anterior uveitis being the most common anatomical form. Idiopathic cases 
accounted for the majority of anterior and intermediate uveitis; toxoplasmosis was the 
most frequent entity in posterior uveitis while Behcet’s disease and idiopathic forms 
were the next most common causes in the Middle East and in Europe, respectively.
Conclusion: Since patterns of uveitis differ in various geographic regions, discovering 
these patterns would be helpful for the diagnosis and treatment of this broad category 
of conditions. This necessitates applying a universal diagnostic classification system 
to enable accurate comparisons.
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INTRODUCTION
Uveitis accounts for 5-20% of legal blindness 
in Europe and the United States1, therefore 
recognition of the prevalence and patterns 
of this diverse group of ocular disorders is 
necessary for their diagnosis and treatment.
Due to the varying prevalence of infectious 
(e.g. tuberculosis and toxoplasmosis) and non-
infectious (e.g. Behçet’s disease) entities in 
different parts of the world, one would expect 
variability in the prevalence and patterns of 
uveitis. This variability may be influenced by 
multiple factors including race and genetic 
background, environmental factors, referral 
patterns, and diagnostic criteria and facilities. 
For instance, in the US, the four most common 
forms of uveitis include acute anterior uveitis 
associated with ankylosing spondylitis, 
sarcoidosis, cytomegalovirus retinitis, and 
toxoplasmosis.2-5 In Japan, the incidence of 
Behçet’s disease, Vogt-Koyanagi-Harada (VKH) 
syndrome, and toxoplasmosis have shown 
an apparent decrease, while the incidence 
of sarcoidosis and acute anterior uveitis are 
increasing.6-8
In the Indian subcontinent, toxoplasmosis, 
VKH syndrome, and idiopathic anterior 
uveitis are most frequently observed.9,10 In 
Africa, AIDS, herpes zoster ophthalmicus, 
toxoplasmosis, tuberculosis (TB), rheumatoid 
arthritis, and onchocerciasis are the most Uveitis in the Middle East and Europe; Nashtaei et al
234 JOURNAL OF OPHTHALMIC AND VISION RESEARCH 2011; Vol. 6, No. 4
commonly associated diseases.11 
The purpose of this study was to compare 
patterns of uveitis in Europe with that in the 
Middle East, and to highlight similarities and 
disparities.
METHODS
Six articles12-17 from the Middle East including 
a sum of 2,693 cases and seven articles from 
Europe18-24 with a total number of 4,379 cases 
were reviewed and compared. First, articles 
originating from the Middle East underwent 
review and data analysis, then they were 
assessed as a whole and general statistics for 
this region were extracted. European articles 
were analyzed similarly followed by comparison 
of data from the two regions. 
Except for the Finnish study20, which 
was community-based, all other reports were 
obtained from tertiary referral centers. In the 
study performed in Israel17, the criteria for 
classification of uveitis were not mentioned. 
Standardization of uveitis nomenclature 
group (SUN) and the criteria used by Perkins 
(1961) were applied in Turkey14 and Finland20 
respectively and the rest had used the 
international uveitis study group (IUSG) criteria 
for this purpose.
Having been classified as an idiopathic and 
independent disease in some articles, all cases 
of pars planitis were considered as idiopathic 
for uniformity. An article from Israel17 only 
reviewed chronic uveitis cases and therefore 
did not represent a comprehensive report 
from that region. Statistical data from some 
articles were not classifiable at all and were 
thus excluded from calculations. For example, 
the Brussels study22 did not include anterior 
uveitis and in studies from Poland19, Italy21 and 
Saudi Arabia15 the number of cases in anatomic 
subgroups was not mentioned.
To present data, we used mean ± standard 
deviations (SDs) and frequencies (percentage). 
To compute these values we used weighted 
means proportional to sample size of a particular 
paper. Whenever there was no information 
about a particular item, we disregarded that 
particular data. All statistical analyses were 
performed using SPSS software version 17.0 
(SPSS Co., Chicago, USA).
RESUlTS
Mean age of participants in Middle Eastern 
and European studies was 35.2 and 39.1 years, 
respectively. Male subjects comprised 52% of 
cases in Middle Eastern and 49.4% of subjects 
in European studies. There was no significant 
difference in terms of age and sex between 
Middle Eastern and European studies; both 
study groups reported the fourth decade of 
life as the most common age for presentation 
of uveitis (Table 1).
In studies from the Middle East, the most 
common anatomical forms, in descending 
order, were anterior (49.6%), pan- (24.9%), 
posterior (15.5%), and intermediate uveitis 
(10.3%); however, in the Ankara study13, 
posterior uveitis (26.6%) was more prevalent 
than panuveitis (20.5%) and in the Israeli 
study17, intermediate uveitis (15.2%) was more 
Middle East
Iran Turkey (Ankara) Turkey Saudi Arabia Saudi Arabia Israel Total
Number 544 300 761 488 200 400 2693
Mean age (SD) 32.3 (15.2) 35.7 (-) 35.4 (15.3) 38 (-) 35 (16) - 35.2
Age range - 5 – 78 3 – 83 3 – 99 7 – 91 6 – 75 3 – 99
Sex, M/F (M%) 238/306 (44) 162/138 (54) 388/373 (51) 264/224 (54) 120/80 (60) 216/184 (54) 1388/1305 (52)
Europe
Italy Poland Finland Italy (Rome) Brussels Amsterdam Switzerland Total
Number 655 563 120 1417 201 865 558 4379
Mean age (SD) 44.4 40.4 35.4 30.7 36.5 42 44 39.1
Age range 10 - 90 2 – 87 - - - - 5-92 -
Sex M/F (M%) 341/314 
(52.1)
263/300 
(46.7)
60/60 
(50)
667/750 
(47.1)
90/111 
(45)
433/432 
(50)
308/250 
(55.2)
2162/2217 
(49.4)
Table 1. Characteristics of uveitis patients in the Middle East and Europe Uveitis in the Middle East and Europe; Nashtaei et al
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frequent than posterior uveitis (14.5%). In 
European studies, anatomical forms in order 
of frequency were anterior (51.3%), posterior 
(23.7%), pan- (15.9%), and intermediate uveitis 
(9.1%); only in the Amsterdam study23 was 
panuveitis (20.4%) more common than posterior 
uveitis (16.4%) and also in the Swiss study24 
intermediate uveitis (10.2%) was more common 
than panuveitis (7.2%), (Table 2). Overall causes 
of uveitis regardless of anatomical forms are 
detailed in Table 3.
In Middle Eastern studies, idiopathic uveitis 
(49.9%) was the most common form of anterior 
uveitis while Behçet’s disease (13.7%), Fuchs 
heterochromic iridocyclitis (FHIC) (8.6%), 
herpes viruses (10.6%), TB (1.9%), and HLA 
B-27 associated disease (not tested in one 
of the Saudi Arabian studies15) followed in 
decreasing order. Behçet’s disease was rather 
frequent in the Ankara report (13%)13 and the 
other study from Turkey (31.3%)14 but was 
uncommon in other Middle Eastern countries. 
FHIC was reported in several cases in Iran 
(17.2%)12, while herpes and TB were more 
often encountered in the two Saudi Arabian 
studies.15,16 In European studies, idiopathic 
anterior uveitis was also the most common 
followed by herpes virus (11.8%), FHIC (10.8%), 
Middle East
  Iran Turkey (Ankara) Turkey Saudi Arabia Saudi Arabia Israel Total
Anterior 209 (38.4) 131 (43.5) 400 (52.5) 293 (60) 119 (59.5) 183 (45.8) 1335 (49.6)
Panuveitis 138 (25.4) 62 (20.5) 214 (28.1) 117 (24) 41 (20.5) 98 (24.5) 670 (24.9)
Posterior 101 (18.6) 80 (26.6) 97 (12.7) 54 (11) 27 (13.5) 58 (14.5) 417 (15.5)
Intermediate 96 (17.6) 27 (9) 51 (6.7) 29 (6) 13 (6.5) 61 (15.2) 277 (10.3)
Europe
  Italy Poland Finland Italy (Rome) Brussels Amsterdam Switzerland Total
Anterior 380 (58) 251 (44.6) 105 (87.8) 696 (49.1) - 471 (54.5) 343 (61.5) 2246 (51.3)
Posterior 171 (26.1) 186 (33) 10 (8.2) 313 (22.1) 100 (49.8) 142 (16.4) 118 (21.1) 1040 (23.7)
Panuveitis 85 (12.9) 85 (15.1) 5 (4) 232 (16.3) 72 (35.8) 176 (20.4) 40 (7.2) 695 (15.9)
Intermediate 19 (2.9) 41 (7.3) 0 (0) 176 (12.4) 29 (14.4) 76 (8.8) 57 (10.2) 398 (9.1)
Table 2. Anatomical types of uveitis in the Middle East and Europe
Middle east
Iran Turkey (Ankara) Turkey Saudi Arabia Israel Total
Idiopathic 226 (41.5) 102 (34) 329 (43.2) 86 (43) 158 (39.5) 1121 (41.6)
Behcet’s Disease 47 (8.6) 78 (26) 245 (32.2) 13 (6.5) 61 (15.3) 474 (17.6)
Toxoplasmosis 55 (10.1) 22 (7.3) 36 (4.7) 13 (6.5) 15 (3.8) 169 (6.3)
Herpes 8 (1.5) 9 (3) 22 (2.9) 32 (16) 20 (5) 149 (5.5)
FHIC 36 (6.6) 8 (2.7) 39 (5.1) 7 (3.5) 6 (1.5) 115 (4.3)
VKH 21 (3.9) 3 (1) 9 (1.2) 5 (2.5) 3 (0.8) 78 (2.9)
TB 8 (1.5) 4 (1.3) 3 (0.4) 21 (10.5) 3 (0.8) 76 (2.8)
HLA-B27 3 (0.6) 5 (1.7) 19 (2.5) 3 (1.5) 12 (3) 42 (1.9)
SO 7 (1.3) 2 (0.7) 1 (0.1) 2 (1) 15 (3.8) 27 (1.2)
Europe
  Italy Poland Finland Italy (Rome) Brussels Amsterdam Switzerland Total
Idiopathic 302 (46.1) 169 (30) 97 (80.8) 710 (50.1) 60 (29.9) 289 (33.4) 203 (36.4) 1830 (41.8)
Toxoplasmosis 116 (17.7) - 4 (3.3) 94 (6.6) 49 (24.4) 83 (9.6) 53 (9.5) 399 (9.1)
Herpes 77 (11.8) - 2 (1.7) 78 (5.5) 4 (2) 30 (3.5) 70 (12.5) 261 (6.0)
FHIC 14 (2.1) - 0 (0) 118 (8.3) 1 (0.5) 53 (6.1) 30 (5.4) 216 (4.9)
HLA-B27 - - - 51 (3.6) 12 (6) 105 (12.1) 89 (15.9) 257 (5.9)
Behcet’s Disease 20 (3.1) - 0 (0) 82 (5.8) 11 (5.5) 7 (0.8) 6 (1.1) 126 (2.9)
TB 46 (7) - 2 (1.7) 25 (1.8) 0 (0) 12 (1.4) - (-) 85 (1.9)
VKH 9 (1.4) - 0 (0) 31 (2.2) 1 (0.5) 7 (0.8) 4 (0.7) 52 (1.2)
SO 0 (0) - 0 (0) 14 (1) 1 (0.5) 0 (0) - (-) 15 (0.3)
Table 3. General causes of uveitis in the Middle East and Europe
FHIC, Fuchs Heterochromic Iridocyclitis; VKH, Vogt-Koyanagi-Harada syndrome; TB, Tuberculosis; SO, Sympathic OphthalmiaUveitis in the Middle East and Europe; Nashtaei et al
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TB (3.2%), and Behçet’s disease (0.3%). Herpes 
viruses, TB, and Behçet’s disease (18.9%, 6.3%, 
and 0.8% respectively) were more common in 
the Italian study18 as compared to other parts 
of Europe while HLA B-27 associated disorders 
were more common in Switzerland (15.9%)24 
and Amsterdam (12.1%)23 and FHIC was more 
frequent in Rome (17%)21, Amsterdam (11.3%)23, 
and Switzerland (8.7%)24 (Table 4).
In Middle Eastern studies, the most 
frequently described etiology of posterior 
uveitis included toxoplasmosis (33.6%), Behçet’s 
disease (17.4%), idiopathic (16%), Eales disease 
(4.4%), toxocariasis (3.9%), acute retinal necrosis 
(3.6%), TB (2.8%), sympathetic ophthalmia 
(1.9%), and VKH syndrome (1.7%). Highly 
prevalent conditions were Behçet’s disease in 
the Ankara (26.3%)13 and in the other Turkish 
(41.2%) study14, Eales disease in the Iranian 
(11.9%)12 and Ankara (5%)13 studies, and TB 
in one of the Saudi Arabian studies (29.6%)16. 
Of seven cases of sympathetic ophthalmia, six 
were reported from Israel17 and from a total 
of 14 cases of toxocariasis, an outstanding 
number of 11 cases was reported from Iran12. 
VKH syndrome was reported only in the 
Turkish study (6.2%)14. In European studies, 
toxoplasmosis (49.2%) was similarly the most 
frequent etiology followed by idiopathic (19.0%), 
acute retinal necrosis (ARN, 3.0%), Behçet’s 
disease (2.4%), TB (1.8%), Eales disease (1.6%), 
toxocariasis (1.4%), and VKH syndrome (0.7%), 
in decreasing order of frequency. ARN was 
rather frequent in the Amsterdam (5.6%)23, 
Rome (3.2%)21, and Brussels (4%)22 studies and 
so was TB in the Italian (4.1%)18 study. The 
frequency of toxocariasis was prominent in the 
Rome study (3.2%)21 and the same was noted 
for Behçet’s disease in Brussels (5%)22. Eales 
disease was only reported in the Amsterdam 
study (9.9%)23 (Table 5). 
In Middle Eastern studies, Behçet’s 
disease (44.8%) was the most common cause 
of panuveitis followed by idiopathic (22.2%), 
VKH (10.9%), multifocal choroiditis panuveitis 
(MCP) (3.8%), toxoplasmosis and sympathetic 
ophthalmia (3.6%), and sarcoidosis (3.4%). 
Behçet’s disease was frequent in Turkey 
(53.8%)14, Ankara (59.7%)13, and Israel (59.2%)17, 
while VKH was common in the Saudi Arabian 
(31.6 and 12.2%)15,16 and Iranian (15.2%)12 
studies. MCP constituted 10.1% of cases in Iran12 
while sympathetic ophthalmia was reported 
in 5.1% of cases in Iran12 and 9.2% of cases in 
Israel17. In European studies, idiopathic uveitis 
was the most common form (31.0%) followed 
by Behçet’s disease (17.7%), toxoplasmosis 
(11.1%), sarcoidosis (8.7%), VKH (2.6%), and 
sympathetic ophthalmia (0.3%). Remarkable 
percentages were reported for Behçet’s disease 
in Rome (35.3%)21, sarcoidosis in Amsterdam 
(18.8%)23 and Brussels (12.5%)22, and VKH in 
Italy (10.6%)18 (Table 6).
In Middle Eastern studies, idiopathic 
intermediate uveitis (82.7%) was most common 
followed by sarcoidosis (4%), multiple sclerosis 
(2%), TB (1.6%), and Behçet’s disease (1.2%). 
Noteworthy percentages were reported for 
Middle East
  Iran Turkey (Ankara) Turkey Saudi Arabia Saudi Arabia Israel Total
Idiopathic 109 (52.2) 51 (38.9) 199 (49.8) 155 (52.9) 58 (48.7) 94 (51.4) 666 (49.9)
Behcet’s Disease 0 (0) 17 (13) 125 (31.3) - 0 (0) 1 (0.5) 143 (13.7)
FHIC 36 (17.2) 8 (6.1) 39 (9.8) 19 (6.5) 7 (5.9) 6 (3.3) 115 (8.6)
Herpes 8 (3.8) 9 (6.9) 22 (5.5) 58 (19.8) 30 (25.2) 15 (8.2) 142 (10.6)
TB 6 (2.9) 2 (1.5) 0 (0) - 9 (7.6) 3 (1.6) 20 (1.9)
Europe
  Italy Poland Finland Italy (Rome) Brussels Amsterdam  Switzerland Total
Idiopathic 220 (57.9) 169 (67.3) 91 (86.7) - - 155 (32.9) - 635 (52.6)
Herpes 72 (18.9) - 2 (1.9) 78 (11.2) - 24 (5.1) 59 (17.2) 235 (11.8)
FHIC 14 (3.7) - 0 (0) 118 (17) - 53 (11.3) 30 (8.7) 215 (10.8)
TB 24 (6.3) - 1 (1) - - 6 (1.3) - 31 (3.2)
Behcet’s Disease 3 (0.8) - 0 (0) - - 0 (0) - 3 (0.3)
Table 4. Etiology of anterior uveitis in the Middle East and Europe
FHIC, Fuchs Heterochromic Iridocyclitis; TB, TuberculosisUveitis in the Middle East and Europe; Nashtaei et al
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sarcoidosis in Iran (7.3%)12 and Turkey (5%)14, 
and for Behçet’s disease in Ankara (11.1%)13. 
In European studies, idiopathic intermediate 
uveitis was also the most prevalent form (91.3%), 
followed by sarcoidosis (3.4%), multiple sclerosis 
(1.7%), TB (0.3%), and Behçet’s disease (0.3%). 
Sarcoidosis was diagnosed in 9.2% and 2.3% 
of subjects in the Amsterdam23 and Rome21 
studies, respectively; percentages for multiple 
sclerosis in the same studies were 5.3% and 
1.1% (Table 7). 
Regardless of anatomical classifications and 
considering all causes of uveitis as a whole, in 
Middle Eastern studies, idiopathic uveitis was 
found to be most common (41.6%) followed by 
Behçet’s disease (17.6%), toxoplasmosis (6.3%), 
herpes viruses (5.5%), FHIC (4.3%), VKH (2.9%), 
TB (2.8%), HLA B-27 associated disorders (1.9%), 
Middle East
Iran Turkey (Ankara) Turkey Saudi Arabia Saudi Arabia Israel Total
Toxoplasmosis 55 (54.5) 22 (27.5) 15 (15.5) 28 (51.9) 12 (44.4) 8 (13.8) 140 (33.6)
Behcet’s Disease 0 (0) 21 (26.3) 40 (41.2) - 0 (0) 2 (3.4) 63 (17.4)
Idiopathic 3 (3) 14 (17.5) 25 (25.8) - 0 (0) 16 (27.6) 58 (16)
Toxocariasis 11 (10.9) 1 (1.3) 0 (0) - 0 (0) 2 (3.4) 14 (3.9)
ARN 9 (8.9) 1 (1.3) 0 (0) - 0 (0) 3 (5.2) 13 (3.6)
Eales 12 (11.9) 4 (5) 0 (0) 0 (0) 0 (0) 0 (0) 16 (4.4)
TB 1 (1) 0 (0) 1 (1) - 8 (29.6) 0 (0) 10 (2.8)
SO 0 (0) 0 (0) 0 (0) - 1 (3.7) 6 (10.3) 7 (1.9)
VKH 0 (0) 0 (0) 6 (6.2) - 0 (0) 0 (0) 6 (1.7)
Europe
Italy Poland Finland Italy (Rome) Brussels Amsterdam Switzerland Total
Toxoplasmosis 103 (60.2) - 4 (40) - 39 (39) 69 (48.6) 51 (43.2) 266 (49.2)
Idiopathic 36 (21.1) - 5 (50) - 17 (17) 22 (15.5) 23 (19.5) 103 (19.0)
ARN 0 (0) - 0 (0) 10 (3.2) 4 (4) 8 (5.6) 4 (3.4) 26 (3.0)
TB 7 (4.1) - 1 (10) - 0 (0) 2 (1.4) 0 (0) 10 (1.8)
Eales 0 (0) - 0 (0) 0 (0) 0 (0) 14 (9.9) 0 (0) 14 (1.6)
Toxocariasis 0 (0) - 0 (0) 10 (3.2) 1 (1) 1 (0.7) 0 (0) 12 (1.4)
Behcet’s Disease 2 (1.2) - 0 (0) - 5 (5) 1 (0.7) 5 (4.2) 13 (2.4)
VKH 0 (0) - 0 (0) - 1 (1) 0 (0) 3 (2.5) 4 (0.7)
SO 0 (0) - 0 (0) - 0 (0) 0 (0) 0 (0) 0 (0)
Table 5. Etiology of posterior uveitis in the Middle East and Europe
ARN, Acute Retinal Necrosis; TB, Tuberculosis; SO, Sympathic Ophthalmia; VKH, Vogt-Koyanagi-Harada syndrome
Middle east
  Iran Turkey (Ankara) Turkey Saudi Arabia Saudi Arabia Israel Total
Behcet’s Disease 47 (34.1) 37 (59.7) 115 (53.8) 30 (25.6) 13 (31.7) 58 (59.2) 300 (44.8)
Idiopathic 31 (22.5) 15 (24.2) 60 (28.1) - 13 (31.7) 4 (4.1) 123 (22.2)
VHK 21 (15.2) 3 (4.8) 4 (1.9) 37 (31.6) 5 (12.2) 3 (3.1) 73 (10.9)
MCP 14 (10.1) 0 (0) 7 (3.3) - 0 (0) 0 (0) 21 (3.8)
SO 7 (5.1) 2 (3.2) 1 (0.5) - 1 (2.4) 9 (9.2) 20 (3.6)
Toxoplasmosis 0 (0) 0 (0) 12 (5.9) - 1 (2.4) 7 (7.1) 20 (3.6)
Sarcoidosis 7 (5.1) 3 (4.8) 2 (0.9) - 6 (14.6) 1 (1) 19 (3.4)
Europe
Italy Poland Finland Italy (Rome) Brussels Amsterdam Switzerland Total
Behcet’s Disease 15 (17.6) - 0 (0) 82 (35.3) 5 (6.9) 6 (3.4) 0 (0) 108 (17.7)
Idiopathic 28 (32.9) - 1 (20) - 24 (33.3) 48 (27.3) 16 (40) 117 (31.0)
Toxoplasmosis 13 (15.3) - 3 (60) - 10 (13.9) 14 (8) 2 (5) 42 (11.1)
Sarcoidosis 3 (3.5) - 0 (0) 2 (0.9) 9 (12.5) 33 (18.8) 6 (15) 53 (8.7)
VHK 9 (10.6) - 0 (0) - 0 (0) 1 (0.6) 0 (0) 10 (2.6)
SO 0 (0) - 0 (0) - 1 (1.4) 0 (0) 0 (0) 1 (0.3)
Table 6. Etiology of panuveitis in the Middle East and Europe
VKH, Vogt-Koyanagi-Harada syndrome; MCP, Multifocal Choroiditis Panuveitis; SO, Sympathic OphthalmiaUveitis in the Middle East and Europe; Nashtaei et al
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sympathetic ophthalmia (1.2%) and sarcoidosis 
(1.1%). Herpes viruses (11.9% and 16%) and TB 
(7.6% and 10.5%) were rather frequent in both 
Saudi Arabian studies15,16; FHIC was scarce in 
the Israeli study17 but sympathetic ophthalmia 
was found in a remarkable proportion (3.8%). 
Other figures worth mentioning were Behcet’s 
disease in Turkey (32.2%)14 and Ankara (26%)13, 
toxoplasmosis (10.1%) and FHIC (6.6%) in Iran12, 
and VKH (7.6%) in one of the Saudi Arabian 
studies15. In European studies, idiopathic uveitis 
was also most common type overall, followed 
by toxoplasmosis (9.1%), herpes viruses (6.0%), 
HLA B-27 associated disorders (5.9%), FHIC 
(4.9%), Behçet’s disease (2.9%), TB (1.9%), 
sarcoidosis (1.4%), VKH (1.2%), and sympathetic 
ophthalmia (0.3%). Idiopathic forms held a high 
share in the Finnish study (80.8%)20. Remarkable 
prevalence rates were noted for VKH in Rome 
(2.2%)21 and Italy (1.4%)18, for toxoplasmosis 
in Brussels (24.4%)22 and Italy (17.7%)18, for 
herpes in Switzerland (12.5%)24 and for TB in 
Italy (7%)18. Although Behçet’s disease was 
not reported at all in the Finnish20 study, it 
was reported in 5.8%, 3.1%, and 5.5% of cases 
in Rome21, Italy18, and Brussels22 respectively. 
Sympathetic ophthalmia was reported in 1% 
(14 cases) in the Rome study21. For FHIC, 
prevalence rates were 8.3% and 6.1% in the 
Rome21 and Amsterdam23 studies respectively 
and HLA-B27 associated disease was found in 
12.1% of cases in the latter study and in 15.9% 
of cases in the Swiss study24 (Table 3).
In both Middle Eastern and European 
studies, toxoplasmosis, herpes viruses, and TB 
were major infectious agents; they were found 
in 6.3%, 5.5%, and 2.8% of Middle Eastern 
and in 9.1%, 6.0%, and 1.9% of European 
cases, respectively. Remarkably frequent non-
infectious causes were Behçet’s disease, FHIC, 
sarcoidosis, and VKH with prevalence rates 
of 17.6%, 4.3%, 1.1%, and 2.9% in the Middle 
East, and 2.9%, 4.9%, 1.4%, and 1.2% in Europe, 
respectively.
DISCUSSION 
Limitations of epidemiological studies on 
uveitis stem from a variety of factors including 
heterogeneity of diagnostic criteria and work-
up, lack of uniform classification systems or 
precise definitions, and the effects of referral and 
selection bias. These factors render comparison 
of epidemiological studies from different regions 
and populations difficult.
Most uveitis studies convey data obtained 
from tertiary referral centers rather than 
population-based information. More complicated 
and severe forms of pan- and posterior uveitis 
may be over-represented at referral centers; in 
contrast, primary care and population-based 
studies tend to report less severe cases such 
as anterior uveitis.
Average age and male to female ratio did 
not differ significantly between Middle Eastern 
and European studies (35.2 versus 39.1 years, 
and 52% versus 49.4%, respectively).
The most frequent anatomic forms, in order 
Middle East
Iran Turkey (Ankara) Turkey Saudi Arabia Saudi Arabia Israel Total
Idiopathic 83 (86.5) 22 (81.5) 47 (92.4) - 9 (69.2) 44 (72.1) 205 (82.7)
Sarcoidosis 7 (7.3) 0 (0) 3 (5.0) - 0 (0) 0 (0) 10 (4)
MS 4 (4.2) 0 (0) 0 (0) - 1 (7.7) 0 (0) 5 (2)
TB 0 (0) 0 (0) 2 (2.5) - 2 (15.4) 0 (0) 4 (1.6)
Behcet’s Disease 0 (0) 3 (11.1) 0 (0) - 0 (0) 0 (0) 3 (1.2)
Europe
Italy Poland Finland Italy (Rome) Brussels Amsterdam Switzerland Total
Idiopathic 18 (94.7) - - 170 (96.6) 19 (65.5) 64 (84.2) 55 (96.5) 326 (91.3)
Sarcoidosis 0 (0) - - 4 (2.3) 1 (3.4) 7 (9.2) 0 (0) 12 (3.4)
MS 0 (0) - - 2 (1.1) 0 (0) 4 (5.3) 0 (0) 6 (1.7)
TB 0 (0) - - 0 (0) 0 (0) 0 (0) 1 (1.8) 1 (0.3)
Behcet’s Disease 0 (0) - - 0 (0) 1 (3.4) 0 (0) 0 (0) 1 (0.3)
Table 7. Etiology of intermediate uveitis in the Middle East and Europe
MS, Multiple Sclerosis; TB, TuberculosisUveitis in the Middle East and Europe; Nashtaei et al
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of frequency, were anterior, pan-, posterior and 
intermediate uveitis in Middle Eastern studies 
(except for the Ankara study13 which was 
similar to European studies, and the Israeli17 
study). The most common anatomic forms in 
European studies included anterior, posterior, 
pan-, and intermediate uveitis (except for the 
Amsterdam study23 which was similar to Middle 
Eastern studies). In comparison to the Middle 
East, posterior uveitis was more common than 
panuveitis in Europe.
Considering anterior uveitis, idiopathic 
cases were comparable in Middle Eastern and 
European studies and were the most prevalent 
category in all studies. Behçet’s disease in 
Turkey14, FHIC in Iran12, and herpes viruses 
in Saudi Arabia15,16 and Israel17 stood next. 
In one Saudi Arabian study16, TB was rather 
frequent. As mentioned above, in all European 
studies, idiopathic cases were the most common 
group; in the Italian study18, herpes viruses, 
TB and FHIC ranked next, and in the Rome21 
and Amsterdam23 studies, FHIC was frequently 
reported. In comparison, Behçet’s disease was 
more frequent in the Middle East while TB, 
FHIC and herpes viruses were more frequent 
in Europe.
Regarding posterior uveitis, in the Middle 
East, toxoplasmosis was the most frequently 
reported cause in Iran12, Ankara13 and Saudi 
Arabia15,16, while Behçet’s disease in Turkey14, 
and idiopathic forms in Israel17 were the 
most prevalent causes. Noteworthy entities 
were toxocariasis, FHIC, and ARN in Iran12, 
VKH syndrome in Turkey14 and sympathetic 
ophthalmia in Israel17. In European studies, 
toxoplasmosis was also the most common cause 
of posterior uveitis in Italy18 and Amsterdam23; 
other causes of considerable importance 
included ARN in Amsterdam23, toxocariasis 
in Rome21, and Behçet’s disease in Brussels22. 
Toxoplasmosis and idiopathic cases were more 
frequent in Europe, while other causes were 
more common in the Middle East.
Concerning panuveitis, in Middle Eastern 
studies, Behçet’s disease was consistently the 
most frequent cause in Iran12, Turkey14, Ankara13, 
and Israel17. In Israel17, toxoplasmosis and 
sympathetic ophthalmia were rather frequent 
but idiopathic cases were less common. VKH 
syndrome in Iran12 and Saudi Arabia15, MCP 
in Iran12, and sarcoidosis in Saudi Arabia16 
were also common. In all European studies 
except for Finland20, idiopathic cases were 
most common, but Behcet’s disease in Italy18 
and Rome21, sarcoidosis in Amsterdam23, 
VKH syndrome in Italy18, and toxoplasmosis 
in Finland20 were other prominent causes. In 
general, Behçet’s disease and VKH were more 
common in the Middle East, while idiopathic 
cases, toxoplasmosis, and sarcoidosis were 
more frequent in Europe.
In terms of intermediate uveitis, idiopathic 
cases held the largest share in both European and 
Middle Eastern reports. Eye-catching prevalence 
rates were noted for sarcoidosis in Iran12 and 
Turkey13, multiple sclerosis in Saudi Arabia16 
and Iran12, TB in Saudi Arabia16 and Behçet’s 
disease in Ankara13. In Europe, other common 
causes of intermediate uveitis were sarcoidosis 
and multiple sclerosis in Amsterdam23.
Overall, in both geographic regions, 
idiopathic uveitis was the most common form 
of intraocular inflammation; in the Middle 
East, Behçet’s disease and toxoplasmosis, and 
in Europe, toxoplasmosis and herpes viruses 
ranked second and third. Behçet’s disease, 
VKH and sympathetic ophthalmia were more 
common in the Middle East while toxoplasmosis 
and HLA-B27 associated disorders were more 
frequent in Europe. Considering infectious 
causes, toxoplasmosis in Europe and TB in the 
Middle East were relatively more prevalent but 
herpes viruses did not show any prominent 
differences in prevalence.
Since uveitic entities follow different 
patterns in different regions and are influenced 
by a variety of factors, epidemiologic studies 
can help improve their diagnosis and treatment. 
Adoption of a universal classification systems 
and population-based studies in all countries 
may provide more reliable data for comparisons 
among different areas.
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